[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:syngap1-related-developmental-and-epileptic-encephalopathy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"SYNGAP1-related developmental and epileptic encephalopathy",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07019922","A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety",[11],"Phase 3","RECRUITING","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:27.285907Z",[],[]]